How Long Does LSD Take to Get Out of Your System?

LSD leaves the bloodstream faster than most people expect. After a typical dose, blood plasma concentrations peak within about 1.5 hours and then decline with an initial half-life of roughly 3.5 to 4 hours, meaning LSD itself is largely undetectable in blood within 12 to 16 hours. But “out of your system” means different things depending on whether you’re asking about the drug’s subjective effects, its presence in blood, or its detectability on a drug test, and those three timelines don’t neatly overlap.

How Quickly LSD Clears From Blood

After swallowing a standard dose of LSD, plasma concentrations rise quickly and peak at around 1.5 hours. A controlled study using a 200-microgram oral dose found that peak blood levels averaged about 4.5 ng/mL, and concentrations remained above the measurable threshold of 0.1 ng/mL for up to 12 hours after dosing.¹ That same study reported a two-phase elimination pattern: an initial half-life of about 3.6 hours during the first 12 hours, followed by slower “terminal” elimination with a half-life averaging nearly 9 hours. In practical terms, most of the LSD is gone from your blood within half a day, but trace amounts can linger into the following day.

Other studies using moderate doses in the 85 to 170 microgram range have reported similar half-lives of about 3.7 to 4 hours.² At smaller “microdoses” of 5 to 20 micrograms, the half-life is shorter, around 2.5 to 2.9 hours, and blood levels drop below detection limits much sooner.³ Sublingual microdoses show a comparable pattern, with a half-life around 3 hours.⁴ So the amount you take matters: a larger dose means more drug in circulation to begin with, and a longer window before blood levels fall below measurable thresholds, even though the percentage cleared per hour stays roughly the same.

Why the Effects Last Longer Than the Drug

One of the most puzzling things about LSD is the mismatch between how fast it clears from blood and how long its psychological effects last. A standard dose produces effects that last an average of about 8 hours, yet the drug’s plasma half-life is only around 3.5 hours.⁵ By hour six or seven, the amount of LSD in your blood is a tiny fraction of its peak, yet many people still feel profoundly altered.

The explanation comes from how tightly LSD binds to serotonin receptors. Structural research has shown that when LSD docks into its primary receptor target in the brain, a sort of molecular “lid” closes over the molecule, trapping it in the binding pocket far longer than the drug persists in the bloodstream.⁶ The receptor keeps signaling even after circulating LSD levels have plummeted. This is why you can feel sober-adjacent in terms of physical side effects while still experiencing perceptual changes hours into a trip. The drug has largely left your blood, but it hasn’t finished its work at the receptor level. That distinction matters because “out of your system” in the pharmacological sense, meaning no longer measurable in plasma, is quite different from “done affecting your brain.”

How the Body Breaks LSD Down

Your liver does the heavy lifting. Enzymes there convert LSD into several breakdown products, the most studied of which is called 2-oxo-3-hydroxy-LSD, often abbreviated O-H-LSD. Research on human liver tissue has confirmed that this metabolite is consistently produced when liver enzymes are exposed to LSD.⁷ O-H-LSD itself is not psychoactive, but it is found in urine at much higher concentrations than LSD itself, which makes it the preferred target for most modern urine-based drug tests.

One of the liver enzymes involved in metabolizing LSD is CYP2D6, and people vary genetically in how active this enzyme is. A pooled analysis of multiple controlled studies found that individuals whose genetics make them “poor metabolizers” at this enzyme had measurably higher total LSD exposure in their blood and longer half-lives compared to people with normally functioning CYP2D6.⁸ Roughly 5 to 10 percent of people of European descent fall into this poor-metabolizer category, and for them, LSD hangs around somewhat longer than average. Peak blood levels weren’t significantly different, though, so it’s not that these people get higher — it’s that the drug takes more time to fully clear.

Drug Testing and Detection Windows

LSD poses a unique challenge for drug testing. The doses are measured in micrograms, which are a thousand times smaller than the milligram doses typical of most recreational drugs. That means the concentrations in blood and urine are extremely low to begin with, and they fall rapidly. Standard workplace immunoassay panels (the kind that screen for amphetamines, cannabis, opioids, and the like) often do not include LSD at all. When LSD testing is performed, it typically requires specialized methods.

Modern laboratory techniques using liquid chromatography paired with tandem mass spectrometry can detect LSD in blood at concentrations as low as 0.01 to 0.025 ng/mL.⁹ ¹⁰ Those are impressively sensitive thresholds, but even with that sensitivity, the detection window in blood is still narrow. For a standard recreational dose, blood tests can generally pick up LSD within about 6 to 12 hours. After that, the drug itself drops below even advanced detection limits.

Urine testing extends the window somewhat, because the metabolite O-H-LSD accumulates in urine at higher concentrations than the parent drug and persists longer. Depending on the dose, hydration status, and the sensitivity of the assay, urine tests targeting O-H-LSD can sometimes detect LSD use for up to two to four days. But this window is far less predictable than, say, the cannabis detection window, and it is highly dependent on dose. A microdose might be undetectable in urine within 24 hours, while a higher dose might be caught two or three days later.

Hair testing is theoretically possible but rarely attempted for LSD, because the concentrations deposited in hair are vanishingly small and few commercial labs offer validated assays for it. In practice, if someone is tested for LSD specifically, the test will almost certainly be a urine or blood screen using advanced instrumentation.

False Positives on LSD Screening

When initial immunoassay screening is used rather than the more precise mass-spectrometry methods, false positives for LSD can occur. Certain medications that affect serotonin levels have been reported to cross-react with LSD immunoassays. Sertraline (sold as Zoloft) and fluoxetine (sold as Prozac) have both been associated with false-positive LSD results on initial screening panels.¹¹ This is one reason that any positive immunoassay result for LSD should be confirmed by a more specific laboratory method before anyone draws conclusions. If you take an SSRI and are worried about this scenario, a confirmatory test will almost always sort it out.

Why LSD Is Hard to Catch on a Test

Beyond the low concentrations involved, LSD itself is chemically fragile in stored samples. A stability study found that LSD in urine was stable for up to four weeks at room temperature when stored properly in amber glass or opaque containers. But at higher temperatures, concentrations dropped by 30 to 40 percent within four weeks. Exposure to light accelerated degradation further, depending on the intensity and wavelength of the light and how close the sample was to the source. Under alkaline conditions with prolonged heat, 10 to 15 percent of LSD converted to an inactive form called iso-LSD, while under acidic conditions that conversion stayed below 5 percent.¹²

What this means practically is that sloppy sample handling can turn a positive into a negative. A urine sample left in a clear container under fluorescent lights in a warm room may lose enough LSD that it drops below the detection threshold before the lab even runs the test. Forensic and clinical labs are aware of this and have protocols for it, but it’s one more reason LSD is the hardest common recreational drug to catch on a drug screen.

How LSD Compares to Other Psychedelics

A randomized, controlled crossover study directly compared the timelines of LSD, psilocybin (the active compound in magic mushrooms), and mescaline (from peyote and San Pedro cacti) in the same group of healthy participants. The results put the differences in sharp relief. Psilocybin’s effects lasted an average of about 5 hours with a plasma half-life of roughly 2.3 hours. LSD’s effects lasted about 8.2 hours with a half-life of about 3.5 hours. Mescaline’s effects were the longest at about 11 hours, yet its plasma half-life was nearly identical to LSD’s at about 3.6 hours.⁵

The mescaline comparison is particularly interesting because it mirrors LSD’s own story: mescaline effects outlast its blood levels by a wide margin, suggesting that receptor-level mechanisms, not just blood concentrations, drive effect duration for several psychedelic compounds. The psilocybin comparison is more intuitive, where a shorter half-life maps neatly onto a shorter experience. For someone wondering which psychedelic clears fastest, psilocybin is gone from both the blood and the subjective experience roughly twice as fast as LSD. From a drug-testing perspective, all three share the same basic challenge: low doses, rapid metabolism, and narrow detection windows.

Tolerance Builds Faster Than the Drug Clears

An unusual feature of LSD is how rapidly tolerance develops. Animal research found that a single dose produced nearly complete tolerance to its behavioral effects within 24 hours, well before the drug and its metabolites would have fully washed out.¹³ That same study noted that this rapid behavioral tolerance was not accompanied by any change in serotonin receptor binding after a single dose; receptor binding changes only appeared after chronic dosing over several days. This suggests that the brain’s quick adaptation to LSD operates through a different mechanism than the longer-term receptor downregulation you’d see with repeated use.

In human terms, this is why taking a second dose of LSD the day after the first is widely reported to produce markedly diminished effects. The drug clears on the same timeline, but the brain’s sensitivity to it resets more slowly, typically taking about a week to return to baseline. This rapid tolerance also means that traces of LSD in your body and tolerance to LSD are separate phenomena. You could test positive for LSD metabolites while already being functionally tolerant to its effects, or conversely, be fully sensitive to a new dose despite testing clean.

LSD and Placental Transfer

One question that comes up less frequently but matters a great deal to those it applies to is whether LSD crosses the placenta. Research in mice using radioactively labeled LSD found that in early pregnancy, about 2.5 percent of the administered dose crossed the placental barrier into the fetus within five minutes. In late pregnancy, that dropped to about 0.5 percent.¹⁴ These are animal data and the percentages should not be taken as exact human equivalents, but they confirm that LSD does reach the fetus and does so rapidly. Given the extreme potency of LSD, where active doses are measured in millionths of a gram, even a small percentage of placental transfer could be pharmacologically meaningful. There is no established safe exposure level during pregnancy, and the ethical impossibility of running controlled human studies on this topic means there likely never will be.

Detecting LSD Analogs

The market for LSD-like substances has expanded in recent years, with analogs such as 1P-LSD, 1cP-LSD, and ALD-52 circulating as research chemicals or sold under various labels. These compounds are thought to act as prodrugs, meaning the body converts them into LSD after ingestion, but they are chemically distinct enough that standard LSD tests may not detect them reliably. Specialized forensic methods have been developed to identify these analogs in blood alongside LSD itself, achieving detection limits of 0.01 ng/mL for each compound.⁹ But these advanced assays are not part of routine drug screening. In most real-world testing scenarios, LSD analogs would not be specifically identified unless a forensic lab was asked to look for them.

This creates a gap in practice. Someone who takes 1P-LSD might metabolize it into regular LSD and test positive for LSD on a sufficiently sensitive confirmatory test, or they might not, depending on the timing and the extent of conversion. Someone else might take 1cP-LSD and have it clear without the standard LSD metabolite ever reaching detectable levels. The pharmacokinetics of these analogs are less well studied than LSD itself, so firm clearance timelines simply aren’t available for most of them. If you’re concerned about detection, treating these analogs as functionally equivalent to LSD in terms of timeline is reasonable, but the reality is that the testing landscape hasn’t fully caught up with the expanding chemistry.